These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint. Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147 [TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery. Haddadi A; Farboud ES; Erfan M; Aboofazeli R J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885 [TBL] [Abstract][Full Text] [Related]
24. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers. Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring. Guo R; Sun XT; Zhang Y; Wang DN; Yang CG; Xu ZR J Colloid Interface Sci; 2018 Nov; 530():465-472. PubMed ID: 29990782 [TBL] [Abstract][Full Text] [Related]
26. Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness. Xia Y; Ribeiro PF; Pack DW J Control Release; 2013 Dec; 172(3):707-14. PubMed ID: 23954731 [TBL] [Abstract][Full Text] [Related]
27. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles. Zhao A; Rodgers VG J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186 [TBL] [Abstract][Full Text] [Related]
28. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288 [TBL] [Abstract][Full Text] [Related]
29. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application. Wu XS Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184 [TBL] [Abstract][Full Text] [Related]
31. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441 [TBL] [Abstract][Full Text] [Related]
32. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol. Yoncheva K; Lambov N; Miloshev S Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298 [TBL] [Abstract][Full Text] [Related]
33. Improving Protein Stability and Controlling Protein Release by Adding Poly (Cyclohexane-1, 4-Diyl Acetone Dimethylene Ketal) to PLGA Microspheres. Wang C; Yu C; Yu K; Teng L; Liu J; Wang X; Sun F; Li Y Curr Drug Deliv; 2015; 12(6):726-35. PubMed ID: 25772152 [TBL] [Abstract][Full Text] [Related]
34. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation. Wang J; Ng CW; Win KY; Shoemakers P; Lee TK; Feng SS; Wang CH J Microencapsul; 2003; 20(3):317-27. PubMed ID: 12881113 [TBL] [Abstract][Full Text] [Related]
35. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins. Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292 [TBL] [Abstract][Full Text] [Related]
36. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. Gabor F; Ertl B; Wirth M; Mallinger R J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498 [TBL] [Abstract][Full Text] [Related]
37. Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray. Wang Y; Yang X; Liu W; Zhang F; Cai Q; Deng X J Microencapsul; 2013; 30(5):490-7. PubMed ID: 23346923 [TBL] [Abstract][Full Text] [Related]
38. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. Jiang G; Woo BH; Kang F; Singh J; DeLuca PP J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925 [TBL] [Abstract][Full Text] [Related]
39. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization. Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157 [TBL] [Abstract][Full Text] [Related]
40. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. Giunchedi P; Conti B; Scalia S; Conte U J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]